Andrea Allmendinger, PhD Ten23 Health AG

Andrea Allmendinger is CSO (Chief Scientific Officer) at Ten23 Health AG and adjunct Professor and Group Leader at the University of Freiburg, researching novel parenteral drug formulations and device solutions to improve stability, usability, and cost of goods.

From 2010 to 2021, she worked at Roche as Principal Scientist, Pharmaceutical Development for parenteral products. Andrea is particularly specialized in the development of freeze dried, parenteral formulations, and process development, optimization and transfer of lyophilization cycles, as well as of high-concentration formulations and device combination products.

Andrea studied Pharmacy at the University of Heidelberg, Germany, and the University College London, UK, and holds a Ph.D. in Pharmaceutical Sciences from the University of Basel, Switzerland. She obtained the venia legendi (German Habilitation) from the University of Freiburg, Germany, in 2021, and also serves as Editor-In-Chief for AAPS Open Journal.